Detalhe da pesquisa
1.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335916
2.
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06.
Haematologica
; 106(10): 2578-2587, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855275
3.
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Haematologica
; 107(4): 996-999, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021604
4.
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report.
Haematologica
; 107(8): 1955-1959, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443561
5.
Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome.
Biol Blood Marrow Transplant
; 22(11): 1983-1987, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27492792
6.
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia.
Haematologica
; 100(6): 786-93, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25749825
7.
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program.
Haematologica
; 98(11): 1718-25, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23753030
8.
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Blood Adv
; 7(16): 4448-4461, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276451
9.
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).
Blood
; 113(18): 4153-62, 2009 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19141862
10.
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial.
Blood Adv
; 4(2): 301-311, 2020 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978214
11.
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07.
Blood Cancer J
; 10(11): 119, 2020 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188164
12.
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program.
Blood Cancer J
; 10(10): 96, 2020 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024084
13.
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Lancet Haematol
; 7(10): e737-e745, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798473
14.
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol.
Leuk Lymphoma
; 60(14): 3482-3492, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31298059
15.
Immunotherapy approaches to treat adult acute lymphoblastic leukemia.
Expert Rev Hematol
; 9(6): 563-77, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27011303
16.
Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells.
Mediterr J Hematol Infect Dis
; 7(1): e2015001, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25574360
17.
Current and future management of Ph/BCR-ABL positive ALL.
Expert Rev Anticancer Ther
; 14(6): 723-40, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24611626
18.
Prognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemia.
Mediterr J Hematol Infect Dis
; 6(1): e2014062, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25237475